Episode 14 – Complex assays with Ian Shoemaker, Beckman Coulter Life Sciences & Dr Oksana Sirenko, Molecular Devices
Posted: 1 November 2022 | Drug Target Review | No comments yet
Tune in to this podcast to hear experts discuss 3D cell models, organoids and the automation of complex cell assays.
In this episode, brought to you by Molecular Devices, we cover three-dimensional (3D) organoids and the automation of complex cell assays. We speak with Ian Shoemaker, Senior Application Scientist at Beckman Coulter Life Sciences and Dr Oksana Sirenko, Senior Manager of Assay Development at Molecular Devices.
Listen now to discover how organoid models are developed, used within our experts’ research and how the automation of 3D organoid analysis will evolve in the future, plus much more!
Key learning points:
- Why 3D cell models and 3D organoids are useful in disease research and drug screening
- What a typical workflow for 3D organoid development and analysis looks like
- How to automate organoid development and analysis workflows
- What the automation of 3D organoid analysis will aid in the research of complex systems.
Make sure you don’t miss any new podcasts from Drug Target Review – sign up here to be notified of releases!
Related topics
Assays, Cell Cultures, Drug Development, Lab Automation, Organoids, Screening, Targets
Related organisations
Beckman Coulter Life Sciences, Molecular Devices